Qiagen (Pecura business) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Qiagen (Pecura business) General Information
Description
Provider of veterinary products distribution services. The company's services include holding of veterinary license for the immunstimulatory cytosine-phosphodiester-guanine (CpG) dinucleotides, presented in synthetic oligodeoxynucleotides (CpG-ODN), which are believed to have promising potential in veterinary applications for livestock and companion animals.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Venlo
- Netherlands
Qiagen (Pecura business) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Qiagen (Pecura business) Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Rolf Hecker | Director |
Qiagen (Pecura business) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|